中国临床新医学
中國臨床新醫學
중국림상신의학
CHINESE JOURNAL OF NEW CLINICAL MEDICINE
2009年
7期
718-720
,共3页
洛伐他汀%高血脂症%疗效%安全性
洛伐他汀%高血脂癥%療效%安全性
락벌타정%고혈지증%료효%안전성
Lovatation%Hyperlipidemia%Efficacy%Safety
目的 观察洛伐他汀治疗72例高血脂症的临床疗效与安全性.方法 选择144例高血脂症患者,随机分为观察组与对照组,各72例.观察组采用洛伐他汀治疗,对照组不采用药物治疗.结果 观察组总有效率88.9%,观察组TC、TG 、LDL-C、LDL/HDL治疗后与治疗前及对照组相比,差异有统计学意义(P<0.05),所有患者在治疗过程中均无明显的毒副作用.结论 洛伐他汀治疗高血脂症具有良好的疗效与安全性.
目的 觀察洛伐他汀治療72例高血脂癥的臨床療效與安全性.方法 選擇144例高血脂癥患者,隨機分為觀察組與對照組,各72例.觀察組採用洛伐他汀治療,對照組不採用藥物治療.結果 觀察組總有效率88.9%,觀察組TC、TG 、LDL-C、LDL/HDL治療後與治療前及對照組相比,差異有統計學意義(P<0.05),所有患者在治療過程中均無明顯的毒副作用.結論 洛伐他汀治療高血脂癥具有良好的療效與安全性.
목적 관찰락벌타정치료72례고혈지증적림상료효여안전성.방법 선택144례고혈지증환자,수궤분위관찰조여대조조,각72례.관찰조채용락벌타정치료,대조조불채용약물치료.결과 관찰조총유효솔88.9%,관찰조TC、TG 、LDL-C、LDL/HDL치료후여치료전급대조조상비,차이유통계학의의(P<0.05),소유환자재치료과정중균무명현적독부작용.결론 락벌타정치료고혈지증구유량호적료효여안전성.
Objective To observe the clinical effect and safety of lovastatin in the treatment of 72 hyperlipidemia patients.Methods One hundred and forty-four hyperlipidemia patients were randomly divided into observation group (72 patients) and compared group (72 patients). The patients in observation group were treated with lovastatin, while those in the compared group were not treated with drugs.Results The total efficiency rate of observation group was 88.9%. The TC, TG, LDL-C, LDL/HDL of observation group after treatment were better than that of compared group (P<0.05). There was no distinct toxic and side effects.Conclusion Lovastatin treating the hyperlipidemia has good effect and safety.
